User profiles for Scott Stuart

Stuart A. Scott, PhD, FACMG

Stanford University
Verified email at stanford.edu
Cited by 14777

[HTML][HTML] Carbon capture and storage (CCS): the way forward

…, J Reimer, DM Reiner, ES Rubin, SA Scott… - Energy & …, 2018 - pubs.rsc.org
Carbon capture and storage (CCS) is broadly recognised as having the potential to play a
key role in meeting climate change targets, delivering low carbon heat and power, …

Biodiesel from algae: challenges and prospects

SA Scott, MP Davey, JS Dennis, I Horst… - Current opinion in …, 2010 - Elsevier
Microalgae offer great potential for exploitation, including the production of biodiesel, but
the process is still some way from being carbon neutral or commercially viable. Part of the …

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …

…, A LLerena, TC Skaar, SA Scott… - Clinical …, 2015 - Wiley Online Library
Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major
depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the …

Efficacy of interpersonal psychotherapy for postpartum depression

MW O'hara, S Stuart, LL Gorman… - Archives of general …, 2000 - jamanetwork.com
Background Postpartum depression causes women great suffering and has negative
consequences for their social relationships and for the development of their infants. Research is …

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

…, DF Kisor, NA Limdi, YM Lee, SA Scott… - Clinical …, 2022 - Wiley Online Library
CYP2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19
genotype impacts clopidogrel active metabolite formation. CYP2C19 intermediate and poor …

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

…, M Whirl‐Carrillo, BF Gage, SA Scott… - Clinical …, 2011 - Wiley Online Library
Warfarin is a widely used anticoagulant with a narrow therapeutic index and large interpatient
variability in the dose required to achieve target anticoagulation. Common genetic variants …

Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS).

…, EA McDade-Montez, W Gamez, S Stuart - Psychological …, 2007 - psycnet.apa.org
The authors describe a new self-report instrument, the Inventory of Depression and Anxiety
Symptoms (IDAS), which was designed to assess specific symptom dimensions of major …

Life-cycle assessment of potential algal biodiesel production in the United Kingdom: a comparison of raceways and air-lift tubular bioreactors

…, E Kazamia, JS Dennis, CJ Howe, SA Scott… - Energy & …, 2010 - ACS Publications
Life-cycle assessment has been used to investigate the global warming potential (GWP) and
fossil-energy requirement of a hypothetical operation in which biodiesel is produced from …

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update

…, M Whirl‐Carrillo, CM Stein, SA Scott… - Clinical …, 2017 - Wiley Online Library
This document is an update to the 2011 Clinical Pharmacogenetics Implementation Consortium
(CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing. Evidence …

Effective treatment for postpartum depression is not sufficient to improve the developing mother–child relationship

DR Forman, MW O'HARA, S Stuart… - Development and …, 2007 - cambridge.org
Maternal depression is prevalent, and puts children at risk. Little evidence addresses whether
treatment for maternal depression is sufficient to improve child outcomes. An experiment …